Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04548648
Title LCCC1841: A Phase 2 Trial of Acalabrutinib in Relapsed/Refractory Primary and Secondary CNS Lymphomas
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors UNC Lineberger Comprehensive Cancer Center
Indications

central nervous system lymphoma

B-cell lymphoma

Therapies

Acalabrutinib

Isavuconazole

Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
Lineberger Comprehensive Cancer Center Recruiting Chapel Hill North Carolina 27599 United States Details
Wake Forest University Comprehensive Cancer Center Recruiting Winston-Salem North Carolina 27157-1096 United States Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field